1. Has the market factored in the full value of AstraZeneca’s potential cancer blockbuster?
A positive outcome of the phase III trial could significantly boost AZ's bottom line and help the company compete in a crowded and highly competitive market for cancer drugs.
2. Lloyds Banking Group tipped for nearly 60% upside
Amidst tighter economics for consumers but also higher interest rates, the UK’s ‘number 1’ high street bank is set to generate more income going forward and, according to Jefferies, that’s something that investors have yet to properly price in.
3. FTSE 100 closes ahead as traders avoid tech stocks
Britain's premier share index closed up by around 57 points, or 0.76%, at 7,642.
4. Next, B&M and Greggs see 'downtrading' boon, but will the switching trend continue?
Amidst the cost of living crisis, it's a simple narrative to grasp. Consumers are increasingly searching and shopping for better value; it is a theme that's clear to see across the wider retail sector for at least the past year.
5. Rolls-Royce and BA owner IAG among only three London stocks for younger UK investors
The top six stocks for the UK investors on the online eToro platform, where the average age of its clients is 34, were all US-listed tech or ‘meme’ stocks.